ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Community Based Control Program Taking Final Shape

April 29, 1977

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas

February 3, 1984

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

European Treatment Regimen Less Toxic Than American Method

April 26, 2013

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994